New creatinine- and cystatin C-based equations to estimate GFR without race

Inker, Lesley A., Eneanya, Nwamaka D., Coresh, Josef, Tighiouart, Hocine, Wang, Dan, Sang, Yingying, Crews, Deidra C., Doria, Alessandro +25 more·2021·New England Journal of Medicine
DOI 10.1056/nejmoa2102953

Cited by (1,001)

Items 101–200 of 1,001

  1. Changes in Alzheimer Disease Blood Biomarkers and Associations With Incident All-Cause Dementia
    Yifei Lü, James Russell Pike, Jinyu Chen, Keenan A. Walker, Kevin Sullivan, Bharat Thyagarajan, Michelle M. Mielke, Pamela L. Lutsey, David S. Knopman, Rebecca F. Gottesman et al. · 2024 · JAMA
  2. Epidemiology of sepsis-associated acute kidney injury in the ICU with contemporary consensus definitions
    Tomonori Takeuchi, Alexander H. Flannery, Lucas J. Liu, Lama Ghazi, Augusto Cama-Olivares, Kiyohide Fushimi, Jin Chen, Sarah C. Huen, Ashita Tolwani, Javier A. Neyra · 2025 · Critical Care
  3. Advances in the management of chronic kidney disease
    Teresa K. Chen, Melanie P. Hoenig, Dorothea Nitsch, Morgan Erika Grams · 2023 · BMJ
  4. Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
    Kai‐Uwe Eckardt, Cynthia Delgado, Hiddo J.L. Heerspink, Roberto Pecoits‐Filho, Ana Catherine Ricardo, Bénédicte Stengel, Marcello A. Tonelli, Michael Cheung, Michel Y. Jadoul, Wolfgang C. Winkelmayer­ et al. · 2023 · Kidney International
  5. Emerging Biomarkers and Advanced Diagnostics in Chronic Kidney Disease: Early Detection Through Multi-Omics and AI
    Sami A. Alobaidi · 2025 · Diagnostics
  6. Artificial Intelligence in Periodontology: A Scoping Review
    James Scott, Alberto M. Biancardi, Oliver P. H. Jones, David Andrew · 2023 · Dentistry Journal
  7. Association between weight-adjusted-waist index and risk of cardiovascular diseases in United States adults: a cross-sectional study
    Haiyang Fang, Feng Xie, Kai Li, Meng Li, Yanqing Wu · 2023 · BMC Cardiovascular Disorders
  8. Association of Cystatin C Kidney Function Measures With Long-term Deficit-Accumulation Frailty Trajectories and Physical Function Decline
    Chenglong Li, Yanjun Ma, Chao Yang, Rong Hua, Wuxiang Xie, Luxia Zhang · 2022 · JAMA Network Open
  9. The Kidney Failure Risk Equation: Evaluation of Novel Input Variables including eGFR Estimated Using the CKD-EPI 2021 Equation in 59 Cohorts
    Morgan Erika Grams, Nigel J. Brunskill, Shoshana H. Ballew, Yingying Sang, Josef Coresh, Kunihiro Matsushita, Aditya Surapaneni, Samira Bell, Juan Jesús Carrero, Gabriel Chodick et al. · 2023 · Journal of the American Society of Nephrology
  10. New and old GFR equations: a European perspective
    Pierre Delanaye, Etienne Cavalier, Hans Pottel, Thomas Stehlé · 2023 · Clinical Kidney Journal
  11. Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
    Perkovic, Vlado, Trimarchi, Hernán, Tesar, Vladimir, Lafayette, Richard, Wong, Muh Geot, Barratt, Jonathan, Suzuki, Yusuke, Liew, Adrian, Zhang, Hong, Carroll, Kevin et al. · 2026 · New England Journal of Medicine
  12. Prescription of guideline‐directed medical therapies in patients with diabetes and chronic kidney disease from the CURE‐CKD Registry, 2019‐2020
    Susanne B. Nicholas, Kenn B. Daratha, Radica Z. Alicic, Cami R. Jones, Lindsey M. Kornowske, Joshua J. Neumiller, Samuel Fatoba, Sheldon Xiaodong Kong, Rakesh Singh, Keith C. Norris et al. · 2023 · Diabetes Obesity and Metabolism
  13. Quantitative Assessment of the Effect of Chronic Kidney Disease on Plasma P-Tau217 Concentrations
    Joshua A. Bornhorst, Carly S. Lundgreen, Stephen D. Weigand, Daniel J. Figdore, Heather J. Wiste, Michael E Griswold, Prashanthi Vemuri, Jonathan Graff‐Radford, David S. Knopman, Petrice Cogswell et al. · 2025 · Neurology
  14. Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control
    Byron C. Jaeger, Adam Phillip Bress, Joshua D. Bundy, Alfred K. Cheung, William C. Cushman, Paul E. Drawz, Karen Johnson, Cora Elizabeth Lewis, Suzanne Oparil, Michael V. Rocco et al. · 2022 · JAMA Cardiology
  15. Removing race from the CKD-EPI equation and its impact on prognosis in a predominantly White European population
    Edouard L. Fu, Josef Coresh, Morgan Erika Grams, Catherine M. Clase, Carl‐Gustaf Elinder, Julie M. Paik, Chava L. Ramspek, Lesley A. Inker, Andrew S. Levey, Friedo Wilhelm Dekker et al. · 2022 · Nephrology Dialysis Transplantation
  16. Dual-Organ Transplantation: Indications, Evaluation, and Outcomes for Heart-Kidney and Heart-Liver Transplantation: A Scientific Statement From the American Heart Association
    Michelle Maya Kittleson, Kavita Sharma, Daniel C. Brennan, Xingxing S. Cheng, Sheryl L. Chow, Monica M Colvin, Adam D. DeVore, Shannon M. Dunlay, Meg Fraser, Jacqueline Garonzik‐Wang et al. · 2023 · Circulation
  17. Polygenic risk alters the penetrance of monogenic kidney disease
    Atlas Khan, Ning Shang, Jordan Gabriela Nestor, Chunhua Weng, George M. Hripcsak, Peter C. Harris, Ali G. Gharavi, Krzysztof Kiryluk · 2023 · Nature Communications
  18. Sensing ultrasound localization microscopy for the visualization of glomeruli in living rats and humans
    Louise Denis, Sylvain Bodard, Vincent Hingot, Arthur Chavignon, Jacques Battaglia, Gilles Renault, Franck Lager, Abderrahmane Walid Aissani, O. Hélénon, Jean-Michel Corréas et al. · 2023 · EBioMedicine
  19. Development and Validation of Prediction Models of Adverse Kidney Outcomes in the Population With and Without Diabetes
    Morgan Erika Grams, Nigel J. Brunskill, Shoshana H. Ballew, Yingying Sang, Josef Coresh, Kunihiro Matsushita, Aditya Surapaneni, Samira Bell, Juan Jesús Carrero, Gabriel Chodick et al. · 2022 · Diabetes Care
  20. Accuracy of GFR estimating equations based on creatinine, cystatin C or both in routine care
    Edouard L. Fu, Andrew S. Levey, Josef Coresh, Morgan Erika Grams, Anne‐Laure Faucon, Carl‐Gustaf Elinder, Friedo Wilhelm Dekker, Pierre Delanaye, Lesley A. Inker, Juan Jesús Carrero · 2023 · Nephrology Dialysis Transplantation
  21. Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure
    Debbie C. Chen, Michael G. Shlipak, Rebecca Scherzer, Nisha Bansal, Onur Potok, Dena E. Rifkin, Joachim H. Ix, Anthony N. Muiru, Chi‐yuan Hsu, Michelle M. Estrella · 2022 · American Journal of Kidney Diseases
  22. Chronic kidney disease is more prevalent among women but more men than women are under nephrological care
    Michał Lewandowski, Simon Krenn, Amelie Kurnikowski, Philipp Bretschneider, Martina Sattler, Elisabeth Schwaiger, Marlies Antlanger, Philipp Gauckler, Markus Pirklbauer, Maria Brunner et al. · 2022 · Wiener klinische Wochenschrift
  23. Kidney-brain axis in the pathogenesis of cognitive impairment
    Qianqian Yan, Mengyuan Liu, Yiling Xie, Yimi Lin, Ping Fu, Yaoyu Pu, Bo Wang · 2024 · Neurobiology of Disease
  24. Discrepancies between Cystatin C–Based and Creatinine-Based eGFR
    Danielle K. Farrington, Aditya Surapaneni, Kunihiro Matsushita, Jesse C. Seegmiller, Josef Coresh, Morgan Erika Grams · 2023 · Clinical Journal of the American Society of Nephrology
  25. The CKD-EPI 2021 Equation and Other Creatinine-Based Race-Independent eGFR Equations in Chronic Kidney Disease Diagnosis and Staging
    Song Lu, Kimberly Robyak, Yusheng Zhu · 2023 · The Journal of Applied Laboratory Medicine
  26. Nephron overload as a therapeutic target to maximize kidney lifespan
    Valérie A. Luyckx, Andrew D. Rule, Katherine R. Tuttle, Pierre Delanaye, Helen Liapis, Afschin Gandjour, Paola Romagnani, Hans‐Joachim Anders · 2021 · Nature Reviews Nephrology
  27. Should Cystatin C eGFR Become Routine Clinical Practice?
    Sebastian Spencer, Robert Desborough, Sunil Bhandari · 2023 · Biomolecules
  28. Long-term outcomes of COVID-19 survivors with hospital AKI: association with time to recovery from AKI
    Justin Lu, Montek Singh Boparai, Caroline Shi, Erin M. Henninger, Mahendranath Rangareddy, Sudhakar Veeraraghavan, Parsa Mirhaji, Molly C. Fisher, Timothy Q. Duong · 2023 · Nephrology Dialysis Transplantation
  29. Proteomics of CKD progression in the chronic renal insufficiency cohort
    Ruth F. Dubin, Rajat Deo, Yue Ren, J. Wang, Zihe Zheng, Haochang Shou, Alan S. Go, Afshin Parsa, James Phillip Lash, Mahboob Rahman et al. · 2023 · Nature Communications
  30. Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial
    Elric Zweck, Christian Hassager, Rasmus Paulin Beske, Lisette Okkels Jensen, Hans Eiskjær, Norman Mangner, Amin Polzin, Paul Christian Schulze, Carsten Skurk, Peter Nordbeck et al. · 2024 · Circulation
  31. Association between atherogenic index of plasma with all-cause and cardiovascular mortality in individuals with Cardiovascular-Kidney-Metabolic syndrome
    Qianrong Zheng, Zhenyang Cao, Jiayi Teng, Qian Lü, Pan Huang, Jianghua Zhou · 2025 · Cardiovascular Diabetology
  32. DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases
    Handelsman, Yehuda, Anderson, John E., Bakris, George L., Ballantyne, Christie M., Beckman, Joshua A., Bhatt, Deepak L., Bloomgarden, Zachary T., Bozkurt, Biykem, Budoff, Matthew J., Butler, Javed et al. · 2022 · Journal of Diabetes and its Complications
  33. Racial and Sex Disparities in Gout Prevalence Among US Adults
    Natalie McCormick, Na Lu, Chio Yokose, Amit D. Joshi, Shanshan Li, Lynn A. Rosenberg, Erica T. Warner, Nicola Dalbeth, Tony Raymond Merriman, Kenneth G. Saag et al. · 2022 · JAMA Network Open
  34. Clonal Hematopoiesis of Indeterminate Potential and Kidney Function Decline in the General Population
    Bryan R. Kestenbaum, Alexander G. Bick, Caitlyn Vlasschaert, Michael J. Rauh, Matthew Bruce Lanktree, Nora Franceschini, Moore Benjamin Shoemaker, Raymond Clement Harris, Bruce M. Psaty, Anna Köttgen et al. · 2022 · American Journal of Kidney Diseases
  35. Association of Urinary Metals With Cardiovascular Disease Incidence and All-Cause Mortality in the Multi-Ethnic Study of Atherosclerosis (MESA)
    Irene Martínez-Morata, Kathrin Schilling, Ronald A. Glabonjat, Arce Domingo‐Relloso, Melanie Mayer, Katlyn E. McGraw, Marta Gálvez-Fernández, Tiffany R. Sanchez, Anne E. Nigra, Joel D. Kaufman et al. · 2024 · Circulation
  36. Sex Differences in Hypertension and Its Management Throughout Life
    Wan-Jin Yeo, Rahul Abraham, Aditya Surapaneni, Pascal Schlosser, Shoshana H. Ballew, Bige Özkan, Carina M. Flaherty, Bing Yu, Joseph Vincent Bonventre, Chirag R. Parikh et al. · 2024 · Hypertension
  37. 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
    Chiadi E. Ndumele, Fátima Rodríguez, Dave L. Dixon, Sadiya S. Khan, Debabrata Mukherjee, Mandeep Singh Bajaj, Sripal Bangalore, Biykem Bozkurt, Khadijah K Breathett, Shoa L. Clarke et al. · 2026 · Circulation
  38. Discordance Between Creatinine-Based and Cystatin C–Based Estimated GFR: Interpretation According to Performance Compared to Measured GFR
    Yeli Wang, Ogechi M. Adingwupu, Michael G. Shlipak, Alessandro Doria, Michelle M. Estrella, Marc Froissart, Vilmundur G. Gudnason, ANDERS O. GRUBB, Roberto Kalil Filho, Michael S. Mauer et al. · 2023 · Kidney Medicine
  39. Serum concentrations of per- and polyfluoroalkyl substances and risk of renal cell carcinoma in the Multiethnic Cohort Study
    Jongeun Rhee, Vicky C. Chang, Iona C. Cheng, Antonia M. Calafat, Julianne Cook Botelho, Joseph J. Shearer, Joshua Neil Sampson, Veronica Wendy Setiawan, Lynne Ross Wilkens, Debra T. Silverman et al. · 2023 · Environment International
  40. Cystatin C as a GFR Estimation Marker in Acute and Chronic Illness: A Systematic Review
    Ogechi M. Adingwupu, Ernesto Rodolpho Barbosa, Paul M. Palevsky, Joseph A. Vassalotti, Andrew S. Levey, Lesley A. Inker · 2023 · Kidney Medicine
  41. Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2024 Clinical Practice Guideline
    Magdalena Madero, Adeera Levin, Sofia Bano Ahmed, Juan Jesús Carrero, Bethany Joy Foster, Anna Francis, Rasheeda K. Hall, William Guy Herrington, Guy Hill, Lesley A. Inker et al. · 2025 · Annals of Internal Medicine
  42. Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses
    Liam Gaziano, Luanluan Sun, Matthew Arnold, Steven Bell, Kelly Cho, Stephen K. Kaptoge, Rebecca J. Song, Stephen Burgess, Daniel C. Posner, Katja Mosconi et al. · 2022 · Circulation
  43. KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases
    Laurence H. Beck, Isabelle M. Ayoub, Dawn J. Caster, Michael Jin Choi, Jason Cobb, Duvuru Geetha, Michelle N. Rheault, Shikha Wadhwani, Timothy T. Yau, William Luke Whittier · 2023 · American Journal of Kidney Diseases
  44. Joint assessment of abdominal obesity and non-traditional lipid parameters for primary prevention of cardiometabolic multimorbidity: insights from the China health and retirement longitudinal study 2011–2018
    Hurong Lai, Yansong Tu, Caifeng Liao, Shan Zhang, Ling He, Jian Li · 2025 · Cardiovascular Diabetology
  45. Higher mortality among lean patients with non-alcoholic fatty liver disease despite fewer metabolic comorbidities
    Wijarnpreecha, Karn, Li, Fang, Lundin, Sori K., Suresh, Deepika, Song, Michael W., Tao, Cui, Chen, Vincent L., Lok, Anna S. F. · 2023 · Alimentary Pharmacology & Therapeutics
  46. The Gut Microbial Metabolite Trimethylamine N-oxide, Incident CKD, and Kidney Function Decline
    Meng Wang, W.H. Wilson Tang, Xinmin S. Li, Marcia C. de Oliveira Otto, Yujin Lee, Rozenn N. Lemaître, Amanda M. Fretts, Ina Nemet, Nona Sotoodehnia, Colleen M. Sitlani et al. · 2024 · Journal of the American Society of Nephrology
  47. Prevalence of SGLT2i and GLP1RA use among US adults with type 2 diabetes
    Limonte, Christine P., Hall, Yoshio N., Trikudanathan, Subbulaxmi, Tuttle, Katherine R., Hirsch, Irl B., de Boer, Ian H., Zelnick, Leila R. · 2022 · Journal of Diabetes and its Complications
  48. Evaluating the Impact and Rationale of Race-Specific Estimations of Kidney Function: Estimations from U.S. NHANES, 2015-2018
    Tsai, Jennifer W., Cerdeña, Jessica P., Goedel, William C., Asch, William S., Grubbs, Vanessa, Mendu, Mallika L., Kaufman, Jay S. · 2021 · eClinicalMedicine
  49. Assessment of Cystatin C Level for Risk Stratification in Adults With Chronic Kidney Disease
    Jennifer Susan Lees, Elaine Rutherford, Kathryn I. Stevens, Debbie C. Chen, Rebecca Scherzer, Michelle M. Estrella, Michael K. Sullivan, Natalie Ebert, Patrick Barry Mark, Michael G. Shlipak · 2022 · JAMA Network Open
  50. Effect of renal function on the diagnostic performance of plasma biomarkers for Alzheimer’s disease
    Bin Zhang, Cheng Zhang, Yuye Wang, Leian Chen, YaNan Qiao, Yu Wang, Dantao Peng, Alzheimer’s Disease Neuroimaging Initiative · 2023 · Frontiers in Aging Neuroscience
  51. Screening for Kidney Disease in Low- and Middle-Income Countries
    Robert Kalyesubula, Andrea L. Conroy, Viviane Cálice-Silva, Vivek Kumar, Ugochi Chika Onu, Anthony Batte, F.F. Kaze, June Fabian, Ifeoma Ulasi · 2022 · Seminars in Nephrology
  52. Association of cardiovascular-kidney-metabolic syndrome with all-cause and cardiovascular mortality: A prospective cohort study
    Jiangtao Li, Xiang Wei · 2025 · American Journal of Preventive Cardiology
  53. Low-density lipoprotein cholesterol, lipoprotein(a) and high-sensitivity C-reactive protein are independent predictors of cardiovascular events
    Marcello Ricardo Paulista Markus, Till Ittermann, Joany Mariño, Sabine Schipf, Martin Bahls, Stephanie Könemann, Bishwas Chamling, Henry Völzke, Nágila Raquel Teixeira Damasceno, Raul Dias Santos et al. · 2025 · European Heart Journal
  54. Multiomic analysis of human kidney disease identifies a tractable inflammatory and pro-fibrotic tubular cell phenotype
    Maximilian Reck, David Baird, Stefan Alexander Veizades, Callum Sutherland, Rachel M. B. Bell, Heeyoun Hur, Carolynn Cairns, Piotr P. Janas, Ross Campbell, Andy Nam et al. · 2025 · Nature Communications
  55. Randomized Trial to Assess the Clinical Utility of Renal Allograft Monitoring by Urine CXCL10 Chemokine
    Patricia Hirt‐Minkowski, Joëlle Handschin, Susanne Stampf, Helmut Hopfer, Thomas Menter, Lisa Senn, Gideon Hönger, Caroline Wehmeier, Patrizia Amico, Jürg U. Steiger et al. · 2023 · Journal of the American Society of Nephrology
  56. The 2021 Chronic Kidney Disease Epidemiology Collaboration Race-Free Estimated Glomerular Filtration Rate Equations in Kidney Disease: Leading the Way in Ending Disparities
    Keyerra Charles, Mary Jane Lewis, Elizabeth Montgomery, Morgan Reid · 2024 · Health Equity
  57. Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional study
    Anna Forbes, William Hinton, Michael D Feher, William H. D. Elson, Mark Joy, José Manuel Ordóñez-Mena, Xuejuan Fan, Nicholas I. Cole, Debasish Banerjee, Rebecca Suckling et al. · 2024 · EClinicalMedicine
  58. Real-World Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis
    Reza Zonozi, Faten F. Aqeel, Dustin Le, Frank B. Cortazar, Jugal Thaker, Maria Jose Zabala Ramirez, Sebastian Eduardo Sattui, Rose Mary Attieh, Madeline Chung, David H. Bulbin et al. · 2024 · Kidney International Reports
  59. Predicting the risks of kidney failure and death in adults with moderate to severe chronic kidney disease: multinational, longitudinal, population based, cohort study
    Ping Liu, Simon Sawhney, Uffe Heide‐Jørgensen, Robert Ross Quinn, Simon Kok Jensen, Andrew Mclean, Christian Fynbo Christiansen, Thomas Alexander Gerds, Pietro Ravani · 2024 · BMJ
  60. Creatinine, cystatin C, muscle mass, and mortality: Findings from a primary and replication population‐based cohort
    Dion Groothof, Naser B.N. Shehab, Nicole Stephanie Erler, Adrian Post, Daan Kremer, Harmke A. Polinder‐Bos, Ron T. Gansevoort, Henk Groen, Robert A. Pol, Rijk O. B. Gans et al. · 2024 · Journal of Cachexia Sarcopenia and Muscle
  61. Which is the best glomerular filtration marker: Creatinine, cystatin C or both?
    Thomas Stehlé, Pierre Delanaye · 2024 · European Journal of Clinical Investigation
  62. Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies
    Mathias Gorski, Humaira Rasheed, Alexander Teumer, Laurent F. Thomas, Sarah E. Graham, Garðar Sveinbjörnsson, Thomas W. Winkler, Felix Günther, Klaus J. Stark, Jin Fang Chai et al. · 2022 · Kidney International
  63. Quantifying Individual-Level Inaccuracy in Glomerular Filtration Rate Estimation
    Tariq Shafi, Xiaoqian Zhu, Seth T. Lirette, Andrew D. Rule, Thomas H. Mosley, Kenneth R. Butler, Michael E. Hall, Pradeep K. Vaitla, James J. Wynn, Maria Clarissa Tio et al. · 2022 · Annals of Internal Medicine
  64. Unbiased Human Kidney Tissue Proteomics Identifies Matrix Metalloproteinase 7 as a Kidney Disease Biomarker
    Daigoro Hirohama, Amin Abedini, Salina Moon, Aditya Surapaneni, Simon T. Dillon, Allison Vassalotti, Hongbo Liu, Tomohito Doke, Victor Martinez, Zaipul I. Md Dom et al. · 2023 · Journal of the American Society of Nephrology
  65. Designing acute kidney injury clinical trials
    Alexander Zarbock, Lui G. Forni, Marlies Ostermann, Claudio Ronco, Sean M. Bagshaw, Ravindra L. Mehta, Rinaldo Bellomo, John A. Kellum · 2023 · Nature Reviews Nephrology
  66. Exploring Renal Function Assessment: Creatinine, Cystatin C, and Estimated Glomerular Filtration Rate Focused on the European Kidney Function Consortium Equation
    Hans Pottel, Pierre Delanaye, Etienne Cavalier · 2023 · Annals of Laboratory Medicine
  67. Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment
    Sylvain Lehmann, Susanna Schraen‐Maschke, Jean‐Sébastien Vidal, Constance Delaby, Luc Buée, Frédéric Blanc, Claire Paquet, Bernadette Allinquant, Stéphanie Bombois, Audrey Gabelle et al. · 2024 · Journal of Neurology Neurosurgery & Psychiatry
  68. A Randomized Controlled Clinical Trial Testing Effects of Lademirsen on Kidney Function Decline in Adults with Alport Syndrome
    Daniel Philip Gale, Oliver Groß, Fang Wang, Rafael José Esteban de la Rosa, Matthew Hall, John Andrew Sayer, Gerald Appel, Ali Hariri, Shiguang Liu, Manish R. Maski et al. · 2024 · Clinical Journal of the American Society of Nephrology
  69. 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome
    Ndumele, Chiadi E., Rodriguez, Fatima, Dixon, Dave L., Khan, Sadiya S., Mukherjee, Debabrata, Bajaj, Mandeep, Bangalore, Sripal, Bozkurt, Biykem, Breathett, Khadijah, Clarke, Shoa L. et al. · 2026 · JACC
  70. KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease
    Michel Y. Jadoul, Ahmed A. Awan, Marina Berenguer, Annette N. Bruchfeld, Fabrizio Fabrizi, David Seth Goldberg, Jidong Jia, Nassim Kamar, Rosmawati Mohamed, Mário Guimarães Pessôa et al. · 2022 · Kidney International
  71. Racial and Ethnic Bias in Risk Prediction Models for Colorectal Cancer Recurrence When Race and Ethnicity Are Omitted as Predictors
    Sara Khor, Eric C. Haupt, Erin Elizabeth Hahn, Lindsay Joe Lyons, Veena Shankaran, Aasthaa Bansal · 2023 · JAMA Network Open
  72. Adherence to Life’s Essential 8 and incident chronic kidney disease: a prospective study of 147,988 UK Biobank participants
    Rui Tang, Xuan Wang, Xiang Li, Hao Ma, Zhaoxia Liang, Yoriko Heianza, Lu Qi · 2023 · American Journal of Clinical Nutrition
  73. Sodium–Glucose Cotransporter 2 Inhibitors for Transthyretin Amyloid Cardiomyopathy: Analyses of Short-Term Efficacy and Safety
    Frederick Lang, Sergio Luis Teruya, Ariel Weinsaft, Margaret Cuomo, Alfonsina Mirabal Santos, Ani Nalbandian, Dimitrios Bampatsias, Mathew S. Maurer · 2024 · European Journal of Heart Failure
  74. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease in Children and Adults: a commentary from the European Renal Best Practice (ERBP)
    Fotini Iatridi, Juan Jesús Carrero, Émilie Cornec-Le Gall, Mehmet Kanbay, Valérie A. Luyckx, Rukshana C. Shroff, Charles Joseph Ferro · 2024 · Nephrology Dialysis Transplantation
  75. Comparative performance of plasma pTau181/Aβ42, pTau217/Aβ42 ratios, and individual measurements in detecting brain amyloidosis
    Sylvain Lehmann, Audrey Gabelle, Marie Duchiron, Germain U. Busto, Mehdi Morchikh, Constance Delaby, Christophe Hirtz, Etienne Mondésert, Jean‐Paul Cristol, Genevieve Barnier-Figue et al. · 2025 · EBioMedicine
  76. Elevation of Donor-derived Cell-free DNA Before Biopsy-proven Rejection in Kidney Transplant
    Jonathan S. Bromberg, Suphamai Bunnapradist, Milagros Samaniego, Sanjiv Anand, Erik Stites, Philippe Gauthier, Zachary Demko, Adam Prewett, Madeleine Armer-Cabral, KYLE E. MARSHALL et al. · 2024 · Transplantation
  77. A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study
    John Dennis, Katherine G Young, Pedro Cardoso, Laura M. Güdemann, Andrew Peter McGovern, Andrew A. Farmer, Rury R. Holman, Naveed A. Sattar, Trevelyan J. McKinley, Ewan R. Pearson et al. · 2025 · The Lancet
  78. Effects of tirzepatide versus insulin glargine on cystatin C-based kidney function: a SURPASS-4 post hoc analysis
    Heerspink, Hiddo J.L., Sattar, Naveed, Pavo, Imre, Haupt, Axel, Duffin, Kevin L., Yang, Zhengyu, Wiese, Russell J., Wilson, Jonathan M., Hemmingway, Andrea, Cherney, David Z.I. et al. · 2023 · Diabetes Care
  79. Integrating CKD Into US Primary Care: Bridging the Knowledge and Implementation Gaps
    Joseph A. Vassalotti, Suelyn Boucree · 2022 · Kidney International Reports
  80. CKD-EPI and EKFC GFR Estimating Equations: Performance and Other Considerations for Selecting Equations for Implementation in Adults
    Lesley A. Inker, Hocine Tighiouart, Ogechi M. Adingwupu, Michael G. Shlipak, Alessandro Doria, Michelle M. Estrella, Marc Froissart, Vilmundur G. Gudnason, ANDERS O. GRUBB, Roberto S. Kalil et al. · 2023 · Journal of the American Society of Nephrology
  81. Measured and genetically predicted protein levels and cardiovascular diseases in UK Biobank and China Kadoorie Biobank
    Lars Lind, Mohsen Mazidi, Robert Clarke, Derrick Bennett, Rui Zheng · 2024 · Nature Cardiovascular Research
  82. External Validation of the American Heart Association PREVENT Cardiovascular Disease Risk Equations
    Britton Scheuermann, Alexandra R. Brown, Trenton D. Colburn, Hisham Hakeem, Chen Hoe Chow, Carl J. Ade · 2024 · JAMA Network Open
  83. Designing Interventions Addressing Structural Racism to Reduce Kidney Health Disparities: A Report from a National Institute of Diabetes and Digestive and Kidney Diseases Workshop
    Deidra C. Crews, Rachel E. Patzer, Lilia Cervantes, Richard Knight, Tanjala S. Purnell, Neil R. Powe, Dawn P. Edwards, Keith C. Norris · 2022 · Journal of the American Society of Nephrology
  84. Cystatin C- and Creatinine-Based Glomerular Filtration Rate Estimation Differences and Muscle Quantity and Functional Status in Older Adults: The Health, Aging, and Body Composition Study
    Onur Potok, Joachim H. Ix, Michael G. Shlipak, Nisha Bansal, Ronit Katz, Stephen B. Kritchevsky, Dena E. Rifkin · 2022 · Kidney Medicine
  85. Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort Study
    Jacqueline V. Aredo, Eunji Choi, Victoria Y. Ding, Martin Carl Tammemägi, Kevin ten Haaf, Sophia J. Luo, Neal D. Freedman, Lynne Ross Wilkens, Loı̈c Le Marchand, Heather A. Wakelee et al. · 2022 · JNCI Cancer Spectrum
  86. Serum Cystatin C for Estimation of GFR
    Michael G. Shlipak, Lesley A. Inker, Josef Coresh · 2022 · JAMA
  87. Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study
    Grace Qian, Xiaosong Wang, Naomi J. Patel, Yumeko Kawano, Xiaoqing Fu, C. Cook, Kathleen M.M. Vanni, Emily Kowalski, Emily Banasiak, Katarina J Bade et al. · 2022 · The Lancet Rheumatology
  88. COVID-19−Associated Acute Kidney Injury and Longitudinal Kidney Outcomes
    Abinet Mathias Aklilu, Sanchit Kumar, James T. Nugent, Yu Yamamoto, Claudia Coronel-Moreno, Bashar A. Kadhim, Sophia C. Faulkner, Kyle D. O’Connor, Farah Yasmin, Jason Henry Greenberg et al. · 2024 · JAMA Internal Medicine
  89. Long-Term Body Mass Index Variability and Adverse Cardiovascular Outcomes
    Zakaria Almuwaqqat, Qin Hui, Chang Liu, Jin J. Zhou, Benjamin F. Voight, Yuk-Lam Anne Ho, Daniel C. Posner, Jason L. Vassy, J. Michael Gaziano, Kelly Cho et al. · 2024 · JAMA Network Open
  90. Prevalence of Alzheimer’s disease pathology in the community
    Dag Aarsland, Anita Lenora Sunde, Diego Tovar, Antoine Leuzy, Tormod Fladby, Henrik Zetterberg, Kaj Blennow, Kübra Tan, Giovanni De Santis, Yara Yakoub et al. · 2025 · Nature
  91. Performance of the 2021 Race-Free CKD-EPI Creatinine- and Cystatin C–Based Estimated GFR Equations Among Kidney Transplant Recipients
    Gregory L. Hundemer, Christine A. White, Patrick Alexander Norman, Greg A. Knoll, Navdeep Tangri, Manish M. Sood, Swapnil S. Hiremath, Kevin D. Burns, Christopher R. McCudden, Ayub Akbari · 2022 · American Journal of Kidney Diseases
  92. The association between visceral adiposity index and decreased renal function: A population-based study
    Zheng Qin, Xinyang Chen, Jiantong Sun, Luojia Jiang · 2023 · Frontiers in Nutrition
  93. Myocardial Injury Thresholds for 4 High-Sensitivity Troponin Assays in U.S. Adults
    John William McEvoy, Olive Tang, Dan Wang, Chiadi E. Ndumele, Josef Coresh, Robert H. Christenson, Elizabeth Selvin · 2023 · Journal of the American College of Cardiology
  94. The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank
    Theresa Hydes, Oliver John Kennedy, Ryan Malcolm Buchanan, Daniel James Cuthbertson, Julie Parkes, Simon DS Fraser, Paul J. Roderick · 2023 · BMC Medicine
  95. Association between questionnaire-based and accelerometer-based physical activity and the incidence of chronic kidney disease using data from UK Biobank: a prospective cohort study
    Xingyuan Zhang, Ye-Mao Liu, Fang Lei, Xuewei Huang, Weifang Liu, Tao Sun, Lijin Lin, Peng Zhang, Jingjing Cai, Xiaojing Zhang et al. · 2023 · EClinicalMedicine
  96. Prescription Patterns for Sodium-Glucose Cotransporter 2 Inhibitors in U.S. Health Systems
    Jung‐Im Shin, Yunwen Xu, Alex R. Chang, Juan Jesús Carrero, Carina M. Flaherty, Amrita Mukhopadhyay, Lesley A. Inker, Saul Blecker, Leora Idit Horwitz, Morgan Erika Grams · 2024 · Journal of the American College of Cardiology
  97. Safety of Kidney Transplantation from Donors with HIV
    Christine M. Durand, Allan B. Massie, Sander S Florman, Tao Liang, Meenakshi M. Rana, Rachel Friedman‐Moraco, Alexander J. Gilbert, Peter G. Stock, Sapna A. Mehta, Shikha G. Mehta et al. · 2024 · New England Journal of Medicine
  98. Moving forward from Cockcroft-Gault creatinine clearance to race-free estimated glomerular filtration rate to improve medication-related decision-making in adults across healthcare settings: A consensus of the National Kidney Foundation Workgroup for Implementation of Race-Free eGFR-Based Medication-Related Decisions
    Wendy L. St. Peter, Andrew S. Bzowyckyj, Tracy L. Anderson-Haag, Linda Awdishu, Michael Blackman, Andrew Bland, Ethan Chan, Christine M. Chmielewski, Cynthia Delgado, Rachel F. Eyler et al. · 2024 · American Journal of Health-System Pharmacy
  99. AHA PREVENT Equations and Cardiovascular Disease Risk in Diverse Health Care Populations
    So Mi Jemma Cho, Michael G. Levin, Robert K. Chen, Ryan Samarakoon, Renae Judy, Katherine Hartmann, Darina Postupaka, Victoria Viscosi, Eric H. Farber‐Eger, Akl C. Fahed et al. · 2025 · Journal of the American College of Cardiology
  100. The Difference Between Cystatin C- and Creatinine-Based Estimated Glomerular Filtration Rate and Risk of Diabetic Microvascular Complications Among Adults With Diabetes: A Population-Based Cohort Study
    Daijun He, Bixia Gao, Jinwei Wang, Chao Yang, Ming‐Hui Zhao, Luxia Zhang · 2024 · Diabetes Care